Value investing message boards image Log on |  Join ($$) Stock market forums image VF "How To" Guide        Welcome, guest! Learn about guest access                       
ValueForum.com Home
• Related Discussion Forum Messages
As a ValueForum member, this section would contain CRL message board posts where the ticker symbol CRL has been mentioned by ValueForum members in posts. Learn more about guest access, and benefits of membership -- we hope you will consider joining ValueForum or trying out our service with a 24 hour trial pass.

• Latest CRL SEC Filings

Filings Format Description Filing Date File/Film Number
4/A  Documents [Amend] Statement of changes in beneficial ownership of securities
Acc-no: 0001127602-18-018890 Size: 4 KB
2018-05-24
S-8  Documents Securities to be offered to employees in employee benefit plans
Acc-no: 0000950103-18-006303 (33 Act)  Size: 80 KB
2018-05-18 333-225046
18847340
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001127602-18-017570 Size: 4 KB
2018-05-16
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001127602-18-017568 Size: 6 KB
2018-05-16
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001127602-18-017564 Size: 6 KB
2018-05-15
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001127602-18-017521 Size: 8 KB
2018-05-15
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001127602-18-017519 Size: 4 KB
2018-05-15
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001127602-18-017517 Size: 20 KB
2018-05-15
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001127602-18-017515 Size: 6 KB
2018-05-15
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001127602-18-017511 Size: 6 KB
2018-05-15
More CRL SEC Filings


Related news from
Tue, 15 May 2018
05:51:34 +0000
Edited Transcript of CRL earnings conference call or presentation 10-May-18 12:30pm GMT
Q1 2018 Charles River Laboratories International Inc Earnings Call
Thu, 10 May 2018
11:12:16 +0000
Charles River: 1Q Earnings Snapshot
The Wilmington, Massachusetts-based company said it had net income of $1.08 per share. Earnings, adjusted for amortization costs and non-recurring costs, were $1.38 per share. The results exceeded Wall ...
Thu, 10 May 2018
11:00:00 +0000
Charles River Laboratories Announces First-Quarter 2018 Results from Continuing Operations
Charles River Laboratories International, Inc. today reported its results for the first quarter of 2018. For the quarter, revenue from continuing operations was $494.0 million, an increase of 10.8% from $445.8 million in the first quarter of 2017.
Wed, 09 May 2018
13:00:01 +0000
Should You Buy Charles River Laboratories (CRL) Before Earnings?
Charles River Laboratories (CRL) is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to earnings beat.
Wed, 09 May 2018
12:02:26 +0000
See what the IHS Markit Score report has to say about Charles River Laboratories International Inc.
Charles River Laboratories International Inc NYSE:CRL
Thu, 03 May 2018
12:00:00 +0000
Charles River Laboratories Announces Extended Relationship with The Michael J. Fox Foundation
Charles River Laboratories International, Inc. (NYSE: CRL) today announced an extension of its long-standing collaboration with The Michael J. Fox Foundation for Parkinson’s Research (MJFF), a leading organization working to support the diagnosis and treatment of Parkinson’s disease (PD). Since 2011, Charles River and MJFF have worked together to accelerate the discovery of therapies for PD. With MJFF support, Charles River has launched a new project, focused on in vivo phenotyping of an α-synuclein knockout model and an α-synuclein A53T knockin model.
Tue, 01 May 2018
12:00:00 +0000
Charles River Laboratories Expands Services for Early Discovery Screening
Charles River Laboratories International, Inc. today announced the expansion of its service capabilities in early discovery screening. Charles River is the first contract research organization to offer clients access to Apricot Designs' Dual Arm system for high-throughput absorption, distribution, metabolism, and excretion to identify potential lead compounds in North America and Europe.
Thu, 12 Apr 2018
20:30:00 +0000
Charles River Laboratories Schedules First-Quarter 2018 Earnings Release and Conference Call
Charles River Laboratories International, Inc. will release first-quarter 2018 financial results on Thursday, May 10th, before the market opens. A conference call has been scheduled to discuss this information on Thursday, May 10th, at 8:30 a.m.
Tue, 10 Apr 2018
17:22:24 +0000
Edited Transcript of CRL presentation 7-Mar-17 6:05pm GMT
Charles River Laboratories International Inc at Raymond James Institutional Investors Conference
Tue, 10 Apr 2018
12:00:00 +0000
Charles River Laboratories Focuses on the Future of Oncology at AACR Annual Meeting 2018
Charles River Laboratories International, Inc. today announced that its team of oncology experts is presenting 13 scientific posters, both independently and collaboratively with clients, and will highlight an enhanced oncology portfolio at the American Association for Cancer Research Annual Meeting.
Mon, 09 Apr 2018
12:00:00 +0000
Charles River Laboratories and PathoQuest Expand Strategic Biologics Partnership
Charles River Laboratories International, Inc. and PathoQuest today announced an expansion of their strategic partnership agreement to provide next-generation sequencing services to the biologics industry.
Tue, 03 Apr 2018
12:30:00 +0000
Charles River Laboratories Completes the Acquisition of MPI Research
Charles River Laboratories International, Inc. announced today that it has completed the previously announced acquisition of MPI Research for approximately $800 million in cash, subject to certain customary adjustments.
Tue, 03 Apr 2018
12:30:00 +0000
Charles River Laboratories Announces Closing of Senior Notes Offering
Charles River Laboratories International, Inc. announced today that it has closed its previously announced offering of $500 million in aggregate principal amount of its 5.5% senior notes due 2026 in an unregistered offering.
Mon, 26 Mar 2018
14:20:08 +0000
Charles River Laboratories Int'l, Inc. -- Moody's assigns B1 to Charles River's unsecured notes; secured term loan upgraded to Ba1
Moody's Investors Service, ("Moody's) assigned a B1 rating to Charles River Laboratories International Inc.'s ("Charles River") proposed $500 million senior unsecured notes. At the same ...
Mon, 26 Mar 2018
12:00:00 +0000
Charles River Laboratories Announces Refinancing of Credit Facilities and Offering of $500 Million of Senior Notes
Charles River Laboratories International, Inc. announced today that it has refinanced its existing $1.0 billion of revolving credit facility due 2021 with a new $1.55 billion revolving credit facility due 2023, and its existing $650.0 million of term loan facility due 2021 with a new $750.0 million term loan facility due 2023 .
Thu, 08 Mar 2018
13:00:00 +0000
Charles River Laboratories Makes Expansions to Global Biologics Infrastructure
Charles River Laboratories International, Inc. recently announced several key expansions to its global Biologics Testing Solutions infrastructure to support the characterization, development, and release of biologics and biosimilars.
Mon, 05 Mar 2018
13:00:00 +0000
Charles River Laboratories to Present at Raymond James and Barclays Conferences
Charles River Laboratories International, Inc. announced today that it will present at the Raymond James 39th Annual Institutional Investors Conference in Orlando, Florida, on Tuesday, March 6th, at 3:25 p.m.
Thu, 01 Mar 2018
19:11:23 +0000
With A -20.00% Earnings Drop Lately, Did Charles River Laboratories International Inc (NYSE:CRL) Underperform Its Industry?
Examining how Charles River Laboratories International Inc (NYSE:CRL) is performing as a company requires looking at more than just a years’ earnings. Below, I will run you through a simpleRead More...



"ValueForum is an active, private, online discussion community for stock & bond market investing. In discussion forums divided into finely grained topics, you will find sophisticated investors trading tips, research, and due diligence on value stocks, income investments, forex, market news, and more. Join in - trade ideas, strategies, current news, via our unique message bulletin boards, stock ratings system, and other online tools specifically geared toward our community."

Random member testimonial: "ValueForum has been the most valuable tool I have ever come across when it comes to managing my investments. I can honestly say that the information shared on ValueForum has led me to retire earlier than expected. This is a wonderful investment site, period." more testimonials »

Email / About | Privacy | Terms of Use | How To / FAQ | Msg Ticker | VF Home | My.vf | BDCs.vf | Energy.vf | REITs.vf | TA.vf
 
Nothing in ValueForum.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by ValueForum.com. ©2003 - 2018, Powered in part by Ticker TechnologiesContact Us

Stock Market Investing Forum - Trading Tips & Research - Online Message Boards